{
    "id": 80145,
    "name": "childhood T-cell acute lymphoblastic leukemia",
    "source": "DOID",
    "definition": "A childhood acute lymphoblastic leukemia that has_material_basis in T-cells. [url:https\\://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=16.07d&ns=NCI_Thesaurus&code=C7953]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        "7933"
    ],
    "termId": "DOID:0080145",
    "evidence": [
        {
            "id": 19568,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CD4CAR-expressing natural killer cells induced tumor cell lysis when co-cultured with a patient-derived CD4-positive pediatric T-cell acute lymphoblastic leukemia cell line in culture (PMID: 29348865).",
            "molecularProfile": {
                "id": 34220,
                "profileName": "CD4 positive"
            },
            "therapy": {
                "id": 9084,
                "therapyName": "CD4CAR",
                "synonyms": null
            },
            "indication": {
                "id": 80145,
                "name": "childhood T-cell acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17177,
                    "pubMedId": 29348865,
                    "title": "Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29348865"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT02999633",
            "title": "Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia (ISLAY)",
            "phase": "Phase II",
            "recruitment": "Terminated",
            "therapies": [
                {
                    "id": 6331,
                    "therapyName": "Isatuximab",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03328104",
            "title": "AflacLL1602 ENCERT",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 8014,
                    "therapyName": "Cyclophosphamide + Etoposide + Everolimus + Nelarabine",
                    "synonyms": null
                }
            ]
        }
    ]
}